Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Haematologica
|
May 10, 2007
Lymphoproliferative disease and acquired C1 inhibitor deficiency
Roberto Castelli, Daniela Lambertenghi Deliliers, Lorenza C Zingale, et al.
Annals of Hematology
|
April 9, 2014
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function
Roberto Castelli, Giorgio Lambertenghi Deliliers, Riccardo Colombo, et al.
Journal of Thrombosis and Thrombolysis
|
October 13, 2017
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
Roberto Castelli, Paolo Gallipoli, Riccardo Schiavon, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2024
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
Nicia I Profili, Roberto Castelli, Antonio Gidaro, et al.
Immunopharmacology and Immunotoxicology
|
January 3, 2012
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients
Roberto Castelli, Giuseppe Gritti, Antonino Cannavò, et al.
Clinical Chemistry and Laboratory Medicine
|
January 27, 2016
Laboratory and clinical risk assessment to treat myelodysplatic syndromes
Antonio Gidaro, Giorgio Lambertenghi Deliliers, Paolo Gallipoli, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 9, 2020
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study
Roberto Castelli, Luigi Bergamaschini, Thomas Teatini, et al.
British Journal of Haematology
|
January 6, 2016
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency
Roberto Castelli, Maddalena Alessandra Wu, Massimo Arquati, et al.
Journal of Clinical Medicine
|
November 13, 2021
Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study
Antonio Gidaro, Roberto Manetti, Alessandro Palmerio Delitala, et al.
Anti-Cancer Drugs
|
August 18, 2021
Risk-tailored treatment of splenic marginal zone lymphoma
Roberto Castelli, Monica Balzarotti, Emanuele Salvi, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Haematologica
|
May 10, 2007
Lymphoproliferative disease and acquired C1 inhibitor deficiency
Roberto Castelli, Daniela Lambertenghi Deliliers, Lorenza C Zingale, et al.
Annals of Hematology
|
April 9, 2014
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function
Roberto Castelli, Giorgio Lambertenghi Deliliers, Riccardo Colombo, et al.
Journal of Thrombosis and Thrombolysis
|
October 13, 2017
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
Roberto Castelli, Paolo Gallipoli, Riccardo Schiavon, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2024
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
Nicia I Profili, Roberto Castelli, Antonio Gidaro, et al.
Immunopharmacology and Immunotoxicology
|
January 3, 2012
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients
Roberto Castelli, Giuseppe Gritti, Antonino Cannavò, et al.
Clinical Chemistry and Laboratory Medicine
|
January 27, 2016
Laboratory and clinical risk assessment to treat myelodysplatic syndromes
Antonio Gidaro, Giorgio Lambertenghi Deliliers, Paolo Gallipoli, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 9, 2020
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study
Roberto Castelli, Luigi Bergamaschini, Thomas Teatini, et al.
British Journal of Haematology
|
January 6, 2016
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency
Roberto Castelli, Maddalena Alessandra Wu, Massimo Arquati, et al.
Journal of Clinical Medicine
|
November 13, 2021
Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study
Antonio Gidaro, Roberto Manetti, Alessandro Palmerio Delitala, et al.
Anti-Cancer Drugs
|
August 18, 2021
Risk-tailored treatment of splenic marginal zone lymphoma
Roberto Castelli, Monica Balzarotti, Emanuele Salvi, et al.
Page
of 7